Recognizing February 3 As Topical Steroid Withdrawal Syndrome Awareness Day.
The resolution aims to enhance awareness around TSWS, which remains under-researched and under-discussed. It notes that a significant number of individuals affected by TSWS experience mental health issues such as anxiety and depression, further stressing the need for public education and support. By declaring an awareness day, the bill seeks to open discussions about the condition, leading to better understanding and management among healthcare providers and patients alike.
House Resolution 174 (HR174) recognizes February 3 as Topical Steroid Withdrawal Syndrome Awareness Day. The resolution highlights the severe condition known as Topical Steroid Withdrawal Syndrome (TSWS), which can result from both intentional and unintentional use of topical steroids that are commonly prescribed for a variety of skin conditions including eczema and psoriasis. The bill underscores that TSWS leads to debilitating symptoms, including skin inflammation, rashes, and psychological distress, impacting the quality of life for many sufferers.
While HR174 serves educational and advocacy purposes, there may be limited direct legislative impact since it functions as a resolution rather than a law. However, the increased awareness it promotes could encourage further research and discourse in the medical community. There could be potential contention among stakeholders regarding the implications of awareness on treatment standards and prescribed practices around topical steroid usage.